Latest Posters

Traditionally, there has been a compromise between performance and sustainability.

The NovaSeq X Plus system enables sequencing of >20,000 genomes per year and delivers data in half the time with a 2.5x improvement in throughput. Breakthrough advancement in chemistry, optics and software contribute to fast, highly accurate and cost-effective data.

Researchers looking to answer complex biological questions often require increased statistical power, larger studies and deeper sequencing methods.

2D cultures often fall short in drug screening when it comes to clinical predictivity, but 3D models and high content services allow accurate and clinically relevant screens.

Download this poster to learn more about organelle marker antibodies, stains for live-cell or fixed-cell imaging and finding the right antibodies and dyes for your organelle research.

Laboratory automation has become ubiquitous in many pharmaceutical and biotechnology laboratories and supports a wide range of applications including drug discovery and development, synthetic biology, food and animal health, clinical diagnostics and many others.

The potential of human pluripotent stem cells (hPSCs) continues to show incredible promise, rapidly progressing through clinical trials for use in treatment of a multitude of diseases. However, historical methods of hPSC culture have remained a barrier of entry into the clinic even with relative success within in vitro cellular research.

For optimal experimentation results, it is essential to select an ultrafiltration device and method that is compatible with the sample that you are working with. Download this poster to discover tips including selecting the right device and much more.

Extractable and leachable (E&L) studies are an important part of successful drug product development. This poster highlights a support application built to help project teams address the challenge of effective data management across product development.

Laboratory processes are often documented on paper, whilst the pressures laboratories face to remain compliant as well as demonstrate their capacity to deliver reliable results continues to escalate. Discover how STARLIMS LES can help you.

The changing landscape for antibody-derived therapeutics, such as bi-specific monoclonal antibodies, Fab fragments and Fc-fusion proteins brings new purification challenges in the downstream processing of these molecules. Standard chromatography resins, such as Protein A, may not result in the most efficient purification process.